美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

台灣微脂體

7.00

0.0000

成交量：- -

成交額：- -

市值：2.95億

市盈率：-10.52

高：7.00

開：7.00

低：7.00

收：7.00

52周最高：7.70

52周最低：4.07

股本：4,207.75萬

流通股本：1,606.67萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.6656

每股收益(LYR):-0.8844

淨資產收益率：-108.77%

總資產收益率：-34.73%

市淨率：52.31

市盈率(LYR):-7.92

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

台灣微脂體

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.tlcbio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

台灣微脂體股份有限公司於1997年11月10日註冊成立。他們是一家臨床階段的專業製藥公司，致力於將其專有的脂質組裝藥物輸送平台與經批準的活性藥物成分（API）相結合的同類最佳新型納米藥物的開發和商業化。他們的BioSeizer脂質製劑技術能夠增加藥物動力學（PK）控制和APIs在疾病或損傷部位的局部持續釋放，並用於其TLC599，TLC399和TLC590程序。他們的NanoX靶向輸送技術能夠延長PK曲線並增強脂質體封裝API在期望位點的分佈，並用於其TLC178項目中。因為他們的產品候選人使用已經批準的API，因此他們有資格利用簡化的505監管通路在美國進行審批。他們已經使用他們的專有技術平台來組裝一個多樣化的產品候選產品組合，以針對疼痛管理，眼科和腫瘤學領域未滿足的醫療需求的重要領域。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TLC/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLC\",,,,,undefined,":{"symbol":"TLC","market":"US","secType":"STK","nameCN":"台灣微脂體","latestPrice":7,"timestamp":1634328000000,"preClose":7,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":16066666,"shares":42077467,"eps":-0.665645,"marketStatus":"未開盤","change":0,"latestTime":"10-15 16:00:00 EDT","open":7,"high":7,"low":7,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.665645,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1781164800000},"marketStatusCode":0,"adr":0,"adrRate":2,"listingDate":1542344400000,"exchange":"NASDAQ","adjPreClose":7,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLC\",,,,,undefined,":{"symbol":"TLC","floatShares":16066666,"roa":"-34.73%","roe":"-108.77%","lyrEps":-0.884353,"shares":42077467,"dividePrice":0,"high":7,"amplitude":0,"preClose":7,"low":7,"week52Low":4.07,"pbRate":"52.31","week52High":7.7,"institutionHeld":0,"latestPrice":7,"eps":-0.665645,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.665645,"open":7,"prevYearClose":4.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-12","symbol":"TLC","fiscalQuarterEnding":"2021/06","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2021-05-14","symbol":"TLC","fiscalQuarterEnding":"2021/03","expectedEps":-0.24,"name":null,"time":"","type":"earning","dateTimestamp":1620964800000,"reportTimeType":"","actualEps":-0.08},{"market":"US","date":"2021-03-30","symbol":"TLC","fiscalQuarterEnding":"2020/12","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1617076800000,"reportTimeType":"","actualEps":-0.26},{"market":"US","date":"2020-10-28","symbol":"TLC","fiscalQuarterEnding":"2020/09","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1603857600000,"reportTimeType":"","actualEps":-0.2},{"market":"US","date":"2020-08-05","symbol":"TLC","fiscalQuarterEnding":"2020/06","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1596600000000,"reportTimeType":"","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.tlcbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0188},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.0641},{"period":"1year","weight":0.2029},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"台灣微脂體股份有限公司於1997年11月10日註冊成立。他們是一家臨床階段的專業製藥公司，致力於將其專有的脂質組裝藥物輸送平台與經批準的活性藥物成分（API）相結合的同類最佳新型納米藥物的開發和商業化。他們的BioSeizer脂質製劑技術能夠增加藥物動力學（PK）控制和APIs在疾病或損傷部位的局部持續釋放，並用於其TLC599，TLC399和TLC590程序。他們的NanoX靶向輸送技術能夠延長PK曲線並增強脂質體封裝API在期望位點的分佈，並用於其TLC178項目中。因為他們的產品候選人使用已經批準的API，因此他們有資格利用簡化的505監管通路在美國進行審批。他們已經使用他們的專有技術平台來組裝一個多樣化的產品候選產品組合，以針對疼痛管理，眼科和腫瘤學領域未滿足的醫療需求的重要領域。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.036925},{"month":2,"riseRate":0.666667,"avgChangeRate":0.043492},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.057189},{"month":4,"riseRate":0.333333,"avgChangeRate":0.084853},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.007665},{"month":6,"riseRate":0.666667,"avgChangeRate":0.077597},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.002789},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.005402},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.03619},{"month":10,"riseRate":0,"avgChangeRate":-0.013222},{"month":11,"riseRate":0.5,"avgChangeRate":-0.002828},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.000473}],"exchange":"NASDAQ","name":"台灣微脂體","nameEN":"Taiwan Liposome Company Ltd","securityTypeName":"存托凭证","adrRate":"1:2"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TLC\",market:\"US\",,,undefined,":null}}